SUPERFICIAL VEIN PRODUCTS HEALTHCARE PROFESSIONALS

EXPERIENCE OUR CVI PORTFOLIO ADVANTAGE

Our comprehensive CVI toolkit empowers you to select the best approach for each patient.

VenaSeal Closure System

VenaSeal Closure System for treatment of superficial vein disease

Nonthermal Adhesive Ablation

Cyanoacrylate Closure

The VenaSeal™ closure system delivers immediate and lasting vein closure with its proprietary medical adhesive formula, with a demonstrated 94.6% closure rate at 5 years.1-4

  • Simple, segmental procedure
  • No tumescent anesthesia
  • Less pain and bruising than thermal energy treatment5
  • No post-procedure compression stockings required*2,3
 
LEARN ABOUT VENASEAL

ClosureFast Procedure

ClosureFast Procedure for treatment of superficial vein disease

Gap-free Thermal Ablation

Radiofrequency Energy Ablation

The ClosureFast™ procedure, with its patented overlap design, is the only RFA procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at 5 years.6,7

  • Patented, gap-free segmental procedure
  • Tumescent anesthesia
  • Less pain and bruising than laser energy treatment8
  • Post-procedure compression stockings required7
 
LEARN ABOUT CLOSUREFAST
*

Some patients may benefit from the use of compression stockings post-procedure.

1

Morrison, N. VeClose 5-Year Follow-up Extension Study Results. Presented at Charing Cross 2019; London, UK.

2

Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular. April 2017;25(2):149-156.

3

Proebstle TM. The European Multicenter Study on Cyanoacrylate Embolization of Refluxing Great Saphenous Veins without Tumescent Anesthesia and without Compression Therapy. Results presented at: Charing Cross 2016; London, UK.

4

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. September 2017;5(5):658-666.

5

Morrison N, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985–994.

6

ClosureFast and ClosureFast RFS Patents. https://www.medtronic.com/content/dam/medtronic-com/global/Corporate/meaningful-innovation/documents/CVG-Patent-Marking.pdf.pdf

7

Proebstle TM, et al. Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous veins. Br J Surg. February 2015;102(3):212-218.

8

Almeida JI, et al. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: A multicenter, single-blinded, randomized study (RECOVERY Study). J Vasc Interv Radiol. 2009 Jun;20(6):752-9.